RubusElite Efficacy Testing of a Novel High Protein, Berry Polyphenol Enriched Dairy Beverage
Muscle Damage, Muscle Soreness, Exercise Performance
About this trial
This is an interventional treatment trial for Muscle Damage
Eligibility Criteria
Inclusion Criteria:
- Between 18-45 Years of age • VO2peak between 35ml/kg/min and 55/ml/kg/min
Exclusion Criteria:
Inability or unwillingness to discontinue use of any nutritional supplement or nutraceutical that may impact performance or recovery
- Have an ongoing injury which will impact their ability to exercise, or a history of landing related lower limb injury
- Being unwilling to consume a dairy product
- Any diagnosis of a psychiatric disorder or taking any anti-psychotic, anxiolytic or anti-depressant medication
- Any use of antibiotic medication within the previous two months or current use of prebiotic or probiotics.
- Any diagnosis of chronic coexisting illness [cardiovascular, gastrointestinal (GI) [to include functional GI disorders, inflammatory bowel disease, coeliac disease, lactose intolerance]
- Have a history of international sporting competition, or recent plyometric training
Sites / Locations
- Waterford Institute of Technology
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Active Comparator
Sham Comparator
RubusElite dairy beverage
'Protein rich' dairy beverage
'Low Protein' dairy beverage
The active treatment is a novel beverage, which has been formulated and developed by food Scientists at UCC. The RubusElite beverage is a science-led formulation of blackberry puree and high protein milk.
The high protein dairy beverage will be a commercially available high protein milk which is commercially produced.
The control beverage will be commercially available Taranis Dalia liquid commercially available low protein milk which will be purchased from the manufacturer for use in this study.